Showing results (381-390 of 514) with videos related to
Sort By:
Pageof 52
Transplantation and Cellular Therapy|October 6, 2020
Matched Family Donor Lymphocyte Infusions as First Cellular Therapy for Patients with Severe Primary T Cell DeficienciesManfred Hoenig, Joachim Roesler, Markus G Seidel, et al.Bioorganic & Medicinal Chemistry Letters|July 23, 2011
Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinasesWilliam J McClellan, Yujia Dai, Cele Abad-Zapatero, et al.The Journal of Allergy and Clinical Immunology|March 21, 2015
B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndromeMaria Carmina Castiello, Samantha Scaramuzza, Francesca Pala, et al.Blood|December 23, 2006
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complicationsManfred Hönig, Michael H Albert, Ansgar Schulz, et al.Journal of Clinical Immunology|November 13, 2014
Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS geneKoichi Oshima, Kohsuke Imai, Michael H Albert, et al.The Journal of Pharmacology and Experimental Therapeutics|March 4, 2009
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growth inhibitionPamela H Franklin, Patricia N Banfor, Paul Tapang, et al.Blood Advances|July 10, 2024
Permissible HLA mismatches in 9/10 unrelated donor pediatric stem cell transplants using HLA-EMMA: an EBMT Inborn Errors Working Party studyErik G J von Asmuth, Fleur Hiensch, Sebastiaan Heidt, et al.Plos One|May 19, 2011
PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapyJianbiao Zhou, Chonglei Bi, Wee-Joo Chng, et al.The Pharmacogenomics Journal|February 4, 2009
Identification of genes that confer tumor cell resistance to the aurora B kinase inhibitor, AZD1152J Guo, M G Anderson, P Tapang, et al.Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitorsZhiqin Ji, Yujia Dai, Cele Abad-Zapatero, et al.Pageof 52